Creo Medical (UK) Probability of Future Stock Price Finishing Over 30.25
| CREO Stock | 14.10 0.15 1.05% |
Creo |
Creo Medical Target Price Odds to finish over 30.25
The tendency of Creo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 30.25 or more in 90 days |
| 14.10 | 90 days | 30.25 | about 1.97 |
Based on a normal probability distribution, the odds of Creo Medical to move over 30.25 or more in 90 days from now is about 1.97 (This Creo Medical Group probability density function shows the probability of Creo Stock to fall within a particular range of prices over 90 days) . Probability of Creo Medical Group price to stay between its current price of 14.10 and 30.25 at the end of the 90-day period is about 89.82 .
Assuming the 90 days trading horizon Creo Medical Group has a beta of -0.41 suggesting as returns on the benchmark increase, returns on holding Creo Medical are expected to decrease at a much lower rate. During a bear market, however, Creo Medical Group is likely to outperform the market. Additionally Creo Medical Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Creo Medical Price Density |
| Price |
Predictive Modules for Creo Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Creo Medical Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Creo Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Creo Medical is not an exception. The market had few large corrections towards the Creo Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Creo Medical Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Creo Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.98 | |
β | Beta against Dow Jones | -0.41 | |
σ | Overall volatility | 4.68 | |
Ir | Information ratio | -0.34 |
Creo Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Creo Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Creo Medical Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Creo Medical Group generated a negative expected return over the last 90 days | |
| Creo Medical Group has high historical volatility and very poor performance | |
| Creo Medical Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 30.8 M. Net Loss for the year was (21.7 M) with profit before overhead, payroll, taxes, and interest of 11.59 M. | |
| Creo Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
Creo Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Creo Stock often depends not only on the future outlook of the current and potential Creo Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Creo Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 313 M | |
| Cash And Short Term Investments | 18.5 M |
Creo Medical Technical Analysis
Creo Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Creo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Creo Medical Group. In general, you should focus on analyzing Creo Stock price patterns and their correlations with different microeconomic environments and drivers.
Creo Medical Predictive Forecast Models
Creo Medical's time-series forecasting models is one of many Creo Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Creo Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Creo Medical Group
Checking the ongoing alerts about Creo Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Creo Medical Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Creo Medical Group generated a negative expected return over the last 90 days | |
| Creo Medical Group has high historical volatility and very poor performance | |
| Creo Medical Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 30.8 M. Net Loss for the year was (21.7 M) with profit before overhead, payroll, taxes, and interest of 11.59 M. | |
| Creo Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.